Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis

BACKGROUND: Triple-negative breast cancer (TNBC) has a poor prognosis, even in its early stages. In the absence of postoperative targeted treatments, intensive adjuvant chemotherapy regimens are proposed. For those favorable histologies, such as apocrine and adenoid cystic carcinoma, which frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilie, Silvia Mihaela, Bacinschi, Xenia Elena, Botnariuc, Inga, Anghel, Rodica Maricela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257362/
https://www.ncbi.nlm.nih.gov/pubmed/30538542
http://dx.doi.org/10.2147/BCTT.S175556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257362/
https://www.ncbi.nlm.nih.gov/pubmed/30538542
http://dx.doi.org/10.2147/BCTT.S175556

Ejemplares similares